Overview: In this webinar, Katie discussed the role hypoxia plays in disease progression and treatment response, specifically in cancer. She also explained the various molecular imaging technologies that can be used to visualize and assess hypoxia in preclinical cancer models. Some modalities that were covered include magnetic resonance imaging (MRI), positron emission tomography
Glioblastomas (GBMs) are the most common malignant primary tumor of the central nervous system, accounting for over half of all gliomas1. With the current gold standard of treatment being surgical resection, magnetic resonance imaging (MRI) continues to play a huge role in defining tumor margins and evaluating treatment response in the clinic. However, while
Overview: Watch our webinar where Professor Marc-Andre Fortin presented about the 3D printing of hydrogels and hydrated substances that have been introduced in various fields of biomedical research including regenerative medicine, cosmetic surgery, orthopedics, and medical physics. However, one of the main challenges faced by 3D printing and bioprinting is geometrical conformity. In
Overview: During this webinar, Dr. Parkins reviewed automated, time-lapse microscopy and image-based cell counting and discuss generating high-quality and robust data using the CytoSMART products offered by Scintica. The system specifications, potential applications, and example data will be discussed for the Lux2, the Lux3 FL, and the OMNI live cell imaging systems. CytoSMART
Overview: In this webinar, Katie reviewed how optical imaging works and provided some common examples of how it’s used within preclinical research. She introduced the Newton 7.0 FT500, an optical imaging system manufactured by Vilber that included bioluminescence, fluorescence, and 3D tomography capabilities. She concluded the webinar by going through some of the
